William E. Bindley - 27 May 2025 Form 4 Insider Report for Guardian Pharmacy Services, Inc. (GRDN)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
29 May 2025, 16:15:11 UTC
Prior SEC filing
01 Apr 2025
Next SEC filing
30 Sep 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Douglas Towns, Attorney-in-Fact

Key filing fact

William E. Bindley filed Form 4 for Guardian Pharmacy Services, Inc. (GRDN) on 29 May 2025.

Key facts

  • This page summarizes William E. Bindley's Form 4 filing for Guardian Pharmacy Services, Inc. (GRDN).
  • 2 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 29 May 2025, 16:15.

Change

  • Previous filing in this sequence was filed on 01 Apr 2025.
  • Current net transaction value: -$83,872,837.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0000903539 Primary reporting owner

BINDLEY WILLIAM E

Relationship
Director, 10%+ Owner
Address
300 GALLERIA PARKWAY SE, SUITE 800, ATLANTA
Signature
/s/ Douglas Towns, Attorney-in-Fact
Signature date
29 May 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

GRDN transaction

Class A Common Stock

Sale

Transaction value
$70,739,525
Shares
-3,508,905
Change %
-58%
Price
$20.16
Shares after
2,591,271
Date
27 May 2025
Ownership
By Bindley Capital Partners I, LLC
Footnotes
F1
GRDN transaction

Class A Common Stock

Sale

Transaction value
$13,133,313
Shares
-651,454
Change %
-25%
Price
$20.16
Shares after
1,939,817
Date
28 May 2025
Ownership
By Bindley Capital Partners I, LLC
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents shares of Class A common stock, par value $0.001 per share, of Guardian Pharmacy Services, Inc. (the "Issuer"), sold pursuant to the Underwriting Agreement, dated May 22, 2025, by and among the Issuer, the selling stockholders party thereto and Raymond James & Associates, Inc., as representative of the several underwriters named therein.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .